埼玉医科大学産婦人科

HOME > 業績 > 2018年

業績

2018年

論文原著

英文

  • Ishihara O, Jwa SC, Kuwahara A, Ishikawa T, Kugu K, Sawa R, Banno K, Irahara M, Saito H
    Assisted reproductive technology in Japan: a summary report for 2016 by the Ethics committee of the Japan Society of Obstetrics and Gynecology.
    Reprod Med Biol. 18(1) :7-16, 2018
  • Harada T, Kuji N, Ishihara O, Ichikawa T, Irahara M, Katagiri Y, Saito H, Harada T, Wada-Hiraike O, Taniguchi F; Ethics Committee in Japan Society of Reproductive Medicine.
    Guideline for cryopreservation of unfertilized eggs and ovarian tissues in Japan Society of Reproductive Medicine: Ethics Committee in Japan Society of Reproductive Medicine.
    Reprod Med Biol. 18(1):3-6, 2018
  • Adamson GD, de Mouzon J, Chambers GM, Zegers-Hochschild F, Mansour R, Ishihara O, Banker M, Dyer S.
    International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2011.
    Fertil Steril. 110(6): 1067-80, 2018
  • Bothun AM, Gao Y, Takai Y, Ishihara O, Seki H, Karger B, Tilly JL, Woods DC.
    Quantitative Proteomic Profiling of the Human Ovary from Early to Mid-Gestation Reveals Protein Expression Dynamics of Oogenesis and Folliculogenesis.
    Stem Cells Dev. 27(11): 723-35, 2018
  • Aoki Y, Ochiai K, Lim S, Aoki D, Kamiura S, Lin H, Katsumata N, Cha SD, Kim JH, Kim BG, Hirashima Y, Fujiwara K, Kim YT, Kim SM, Chung HH, Chang TC, Kamura T, Takizawa K, Takeuchi M, Kang SB.
    Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer.
    Br J Cancer. 119(5): 530-7, 2018
  • Ohashi Y, Ikeda M, Kunitoh H, Sasako M, Okusaka T, Mukai H, Fujiwara K, Nakamura M, Kimura T, Ibusuki K, Sakon M.
    Venous thromboembolism in patients with cancer: design and rationale of a multicentre, prospective registry (Cancer-VTE Registry).
    BMJ Open. 8(5):e018910. doi: 10.1136/bmjopen-2017-018910, 2018
  • Pujade-Lauraine E, Fujiwara K, Dychter SS, Devgan G, Monk BJ.
    Avelumab (anti-PD-L1) in platinum-resistant/refractory ovarian cancer: JAVELIN Ovarian 200 Phase III study design.
    Future Oncol. 14(21): 2103-13, 2018
  • Eskander RN, Kauderer J, Tewari KS, Mannel RS, Bristow RE, O’Malley DM, Rubin SC, Glaser GE, Hamilton CA, Fujiwara K, Huh WK, Ueland F, Stephan JM, Burger RA.
    Correlation between Surgeon’s assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study.
    Gynecol Oncol. 149(3): 525-30, 2018
  • Suzumori N, Sekizawa A, Takeda E, Samura O, Sasaki A, Akaishi R, Wada S, Hamanoue H, Hirahara F, Kuriki H, Sawai H, Nakamura H, Yamada T, Miura K, Masuzaki H, Yamashita T, Kamei Y, Namba A, Murotsuki J, Tanemoto T, Fukushima A, Haino K, Tairaku S, Matsubara K, Maeda K, Kaji T, Ogawa M, Osada H, Nishizawa H, Okamoto Y, Kanagawa T, Kakigano A, Endo M, Kitagawa M, Ogawa M, Izumi S, Katagiri Y, Takeshita N, Kasai Y, Naruse K, Neki R, Masuyama H, Hyodo M, Kawano Y, Ohba T, Ichizuka K, Nagamatsu T, Watanabe A, Nishikawa N, Hamajima N, Shirato N, Yotsumoto J, Nishiyama M, Koide K, Hirose T, Sago H.
    Classification of factors involved in nonreportable results of noninvasive prenatal testing (NIPT) and prediction of success rate of second NIPT.
    Prenat Diagn. doi: 10.1002/pd.5408. [Epub ahead of print], 2018
  • Hasegawa J, Wada S, Kasamatsu A, Nakamura M, Hamanoue H, Iwata E, Murotsuki J, Nagai R, Tateishi Y, Sunami R, Tajima A, Murata S, Matsubara K, Nakata M, Kondo A, Nishiyama M, Sasaki A, Sekizawa A, Sago H, Kamei Y; Study group for first trimester Combined Test (FCTG).
    Distribution of PAPP-A and total hCG between 11 and 13 weeks of gestation in Japanese pregnant women.
    J Matern Fetal Neonatal Med. doi: 10.1080/14767058.2018.1536737. [Epub ahead of print], 2018
  • Yamada T, Sekizawa A, Fujii Y, Hirose T, Samura O, Suzumori N, Miura K, Sawai H, Hirahara F, Murotsuki J, Kamei Y, Sago H; Japan NIPT consortium*.
    Correction: Maternal age-specific risk for trisomy 21 based on the clinical performance of NIPT and empirically derived NIPT age-specific positive and negative predictive values in Japan.
    J Hum Genet. 63(10): 1097-8, 2018
  • Yamada T, Sekizawa A, Fujii Y, Hirose T, Samura O, Suzumori N, Miura K, Sawai H, Hirahara F, Murotsuki J, Kamei Y, Sago H; Japan NIPT consortium*.
    Maternal age-specific risk for trisomy 21 based on the clinical performance of NIPT and empirically derived NIPT age-specific positive and negative predictive values in Japan.
    J Hum Genet. 63(10): 1035-40, 2018
  • Toshimitsu M, Kamei Y, Ichinose M, Seyama T, Imada S, Iriyama T, Fujii T.
    Atomoxetine, a selective norepinephrine reuptake inhibitor, improves short-term histological outcomes after hypoxic-ischemic brain injury in the neonatal male rat.
    Int J Dev Neurosci. 70: 34-45, 2018
  • Suzumori N, Sekizawa A, Ebara T, Samura O, Sasaki A, Akaishi R, Wada S, Hamanoue H, Hirahara F, Izumi H, Sawai H, Nakamura H, Yamada T, Miura K, Masuzaki H, Yamashita T, Okai T, Kamei Y, Namba A, Murotsuki J, Tanemoto T, Fukushima A, Haino K, Tairaku S, Matsubara K, Maeda K, Kaji T, Ogawa M, Osada H, Nishizawa H, Okamoto Y, Kanagawa T, Kakigano A, Kitagawa M, Ogawa M, Izumi S, Katagiri Y, Takeshita N, Kasai Y, Naruse K, Neki R, Masuyama H, Hyodo M, Kawano Y, Ohba T, Ichizuka K, Nagamatsu T, Watanabe A, Shirato N, Yotsumoto J, Nishiyama M, Hirose T, Sago H.
    Fetal cell-free DNA fraction in maternal plasma for the prediction of hypertensive disorders of pregnancy.
    Eur J Obstet Gynecol Reprod Biol. 224: 165-9, 2018
  • Seyama T, Kamei Y, Iriyama T, Imada S, Ichinose M, Toshimitsu M, Fujii T, Asou H.
    Pretreatment with magnesium sulfate attenuates white matter damage by preventing cell death of developing oligodendrocytes.
    J Obstet Gynaecol Res. 44(4): 601-7, 2018
  • Hasegawa K, Ikeda Y, Kunugi Y, Kurosaki A, Imai Y, Kohyama S, Nagao S, Kozawa E, Yoshida K, Tsunoda T, Nakamura Y, Fujiwara K.
    Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical Cancer.
    J Immunother. 41(4): 201-7, 2018
  • Oda K, Hamanishi J, Matsuo K, Hasegawa K.
    Genomics to immunotherapy of ovarian clear cell carcinoma: Unique opportunities for management.
    Gynecol Oncol. 151(2): 381-9, 2018
  • Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Hakam A, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD.
    Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element.
    Surg Oncol. 27(3): 433-40, 2018
  • Matsuo K, Ross MS, Yunokawa M, Johnson MS, Machida H, Omatsu K, Klobocista MM, Im DD, Satoh S, Baba T, Ikeda Y, Bush SH, Hasegawa K, Blake EA, Takekuma M, Shida M, Nishimura M, Adachi S, Pejovic T, Takeuchi S, Yokoyama T, Ueda Y, Iwasaki K, Miyake TM, Yanai S, Nagano T, Takano T, Shahzad MM, Ueland FR, Kelley JL, Roman LD.
    Clinical utility of CA-125 in the management of uterine carcinosarcoma.
    J Gynecol Oncol. 29(6):e88. doi: 10.3802/jgo.2018.29.e88. No abstract available, 2018
  • Yano M, Yasuda M, Sakaki M, Nagata K, Fujino T, Arai E, Hasebe T, Miyazawa M, Miyazawa M, Ogane N, Hasegawa K, Narahara H.
    Association of histone deacetylase expression with histology and prognosis of ovarian cancer.
    Oncol Lett. 15(3): 3524-31, 2018
  • Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Hakam A, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Enomoto T, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD.
    Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma.
    Ann Surg Oncol. 25(12): 3676-84, 2018
  • Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Hakam A, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Enomoto T, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD.
    Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma.
    Ann Surg Oncol. 25(9): 2756-66, 2018
  • Matsuo K, Ross MS, Im DD, Klobocista MM, Bush SH, Johnson MS, Takano T, Blake EA, Ikeda Y, Nishimura M, Ueda Y, Shida M, Hasegawa K, Baba T, Adachi S, Yokoyama T, Satoh S, Machida H, Yanai S, Iwasaki K, Miyake TM, Takeuchi S, Takekuma M, Nagano T, Yunokawa M, Pejovic T, Omatsu K, Shahzad MMK, Kelley JL, Ueland FR, Roman LD.
    Significance of venous thromboembolism in women with uterine carcinosarcoma.
    Gynecol Oncol. 148(2): 267-74, 2018
  • Matsuo K, Johnson MS, Im DD, Ross MS, Bush SH, Yunokawa M, Blake EA, Takano T, Klobocista MM, Hasegawa K, Ueda Y, Shida M, Baba T, Satoh S, Yokoyama T, Machida H, Ikeda Y, Adachi S, Miyake TM, Iwasaki K, Yanai S, Takeuchi S, Nishimura M, Nagano T, Takekuma M, Shahzad MMK, Pejovic T, Omatsu K, Kelley JL, Ueland FR, Roman LD.
    The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma.
    J Surg Oncol. 117(3): 488-96, 2018
  • Imai Y, Hasegawa K, Matsushita H, Fujieda N, Sato S, Miyagi E, Kakimi K, Fujiwara K.
    Expression of multiple immune checkpoint molecules on T cells in malignant ascites from epithelial ovarian carcinoma.
    Oncol Lett. 15(5): 6457-68, 2018
  • Yasuda S, Iuchi T, Goto A, Katanoda K, Iida S, Oikawa Y, Namba A, Isshiki M, Inoue I, Kamei Y, Shimada A, Noda M.
    Weight control before and during pregnancy for patients with gestational diabetes mellitus.
    J Diabetes Investig. doi: 10.1111/jdi.12989. [Epub ahead of print],2018
  • Kimura M, Kajihara T, Mizuno Y, Sato T, Ishihara O.
    Loss of high-mobility group N5 contributes to the promotion of human endometrial stromal cell decidualization.
    Reprod Med Biol. 17(4): 493-9, 2018
  • Ogawa K, Morisaki N, Kobayashi M, Jwa SC, Tani Y, Sago H, Horikawa R, Fujiwara T
    Maternal vegetable intake in early pregnancy and wheeze in offspring at the age of 2 years.
    ur J Clin Nutr. 72(5):761-71, 2018
  • Ogawa K, Morisaki N, Kobayashi M, Jwa SC, Tani Y, Sago H, Horikawa R, Fujiwara T
    Reply to Shakira et al.: Validation of a food frequency questionnaire for Japanese pregnant women in mid to late pregnancy.
    Eur J Clin Nutr. doi:10.1038/s41430-018-0263-2. [Epub ahead of print], 2018
  • Yano M, Asami Y, Nishikawa T, Yoshida S, Kamada K, Katoh T, Teramoto Y, Nakamura Y, Yasuda M Immune checkpoint inhibitors of CTLA4 and PD-1 for malignant melanoma arising in ovarian cystic teratoma: A case report.
    Medicine (Baltimore) 2018; 97: e12937.
  • Shimoi T, Hamada A, Yamagishi M, Hirai M, Yoshida M, Nishikawa T, Sudo K, Shimomura A, Noguchi E, Yunokawa M, Yonemori K, Shimizu C, Kinoshita T, Fukuda T, Fujiwara Y, Tamura K.
    PIK3CA mutation profiling in patients with breast cancer, using a highly sensitive detection system.
    Cancer Sci 2018; 109: 2558-66.
  • Matsuo K, Yabuno A, Hom MS, Shida M, Kakuda M, Adachi S, Mandelbaum RS, Ueda Y, Hasegawa K, Enomoto T, Mikami M, Roman LD.
    Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer.
    Gynecol Oncol. 149(2): 301-9, 2018
  • Kato T, Matsuda T, Ikeda Y, Park JH, Leisegang M, Yoshimura S, Hikichi T, Harada M, Zewde M, Sato S, Hasegawa K, Kiyotani K, Nakamura Y.
    Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells.
    Oncotarget. 9(13): 11009-9, 2018
  • Onishi H, Ishida M, Uchida N, Shintani D, Nishikawa T, Hasegawa K, Fujiwara K, Akechi T.
    Subclinical thiamine deficiency identified by preoperative evaluation in an ovarian cancer patient: Diagnosis and the need for preoperative thiamine measurement.
    Palliat Support Care. doi: 10.1017/S1478951518000615. [Epub ahead of print], 201

邦　文

  • 永田一郎、岡垣竜吾、宮崎加寿子、仲神宏子、鈴木裕之、石原　理、佐久間洋、羽生真由子
    経腟的仙棘靭帯腟挙上術　－メッシュを介する新しい手法（Mesh-SSLS）－
    日本女性骨盤底医学会誌 2018;15:145
  • 黒崎　亮、藤原恵一、長谷川幸清
    婦人科がんにおけるHDAC inhibitorの有用性に関する基礎的研究
    埼玉医科大学雑誌44(2): 115-7, 2018

論文総説

邦文

  • 中村　恵、石原　理
    判決紹介　母体保護法上の人工妊娠中絶処置における医学的適応の有無並びに本人及び配偶者の同意の有無が争われた事例
    医事法学33: 230-9, 2018 
  • 石原　理
    生殖補助医療の潮流
    日本産科婦人科学会雑誌70(9): 1807-10, 2018 
  • 石原　理
    性同一性障害
    臨床婦人科産科72(4): 87-9, 2018 
  • 藤原恵一、池田正樹、沼上奈美、山口温子、毛利光子、青谷恵利子、藤原康弘、中野隆史
    NRG Oncology-Japanについて
    腫瘍内科21(1): 109-17, 2018
  • 藤原恵一
    【婦人科がん(第2版)－最新の研究動向－】婦人科がん　概論　国際共同研究の最新情報
    日本臨床76(増刊2): 88-94, 2018 
  • 亀井良政
    【今さら聞けない産婦人科診療のコツとトラブル対処法】吸引・鉗子分娩　急速遂娩のコツと合併症対策
    産婦人科の実際67(12): 1593-9, 2018
  • 岡垣竜吾
    【骨盤臓器脱の治療法up to date】総論　分類と診断
    産婦人科の実際67(2): 127-34, 2018
  • 梶原　健
    【産婦人科外来パーフェクトガイド－いまのトレンドを逃さずチェック！】症状編　代表的な症状からの疾患鑑別《婦人科外来》　不正性器出血/過多月経／希発月経
    臨床婦人科産科72(4): 11-5, 2018
  • 長谷川幸清、新谷大輔、藤原恵一
    婦人科がんにおける免疫チェックポイント阻害薬開発の現状と今後の見通し
    がん分子標的治療16(3): 310-2, 2018
  • 長谷川幸清、佐藤　翔、西川忠曉
    【がん免疫療法の新展開－「知らない」ではすまない今のトレンド】婦人科がんに対する免疫療法　卵巣がんに対する免疫療法の動向
    臨床婦人科産科72(6): 566-71, 2018 
  • 長谷川幸清
    【Gynecologic Tumor　婦人科腫瘍　婦人科Rare Tumorに対する化学療法】子宮平滑筋肉腫の薬物療法
    癌と化学療法45(2): 243-6, 2018
  • 永田一郎、岡垣竜吾、石原　理、佐久間洋
    POP手術のコツ　Native Tissue Repair（NTR）のコツ
    日本女性骨盤底医学会誌15(1):ページ数, 2018 
  • 吉田裕之
    話題のくすり　オラパリブ
    日本病院薬剤師会雑誌54(9): 1147-51, 2018 
  • 難波　聡、岡島多希
    【産婦人科外来パーフェクトガイド－いまのトレンドを逃さずチェック！】疾患編　周産期《周産期疾患》　異所性妊娠
    臨床婦人科産科72(4): 192-5, 2018 
  • 難波　聡
    【産婦人科医も知っておきたい　女性アスリートのヘルスケア–基礎知識から治療指針まで】妊娠中・産褥期の適切なトレーニングとは
    産科と婦人科85(4): 454-8, 2018
  • 木村真智子、石原　理
    女性不妊の原因
    Modern Physician38(7): 719-21, 2018 
  • 西川忠曉、米盛　勧、長谷川幸清、藤原康弘、藤原恵一
    【Gynecologic Tumor　婦人科腫瘍　婦人科Rare Tumorに対する化学療法】子宮癌肉腫に対する薬物療法の現状と今後の展望
    癌と化学療法45(2): 234-8, 2018 
  • 西川忠曉、米盛　勧、長谷川幸清、藤原康弘、藤原恵一
    【泌尿生殖器がん、婦人科がん、成人骨軟部肉腫、原発不明がん】肉腫　肉腫に対するチェックポイント阻害薬の開発動向
    腫瘍内科21(1): 81-7, 2018 
  • 西川忠曉、大熊ひとみ、田村研治
    PARP阻害薬
    がん分子標的治療15(4): 408-13, 2018

トップへ戻る